We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
As biomedical entrepreneurs seek to apply the newest biomedical research results to invest new treatment options that might help patients, a “valley of death” in funding availability continues to endure between the academic researcher and therapies ready to begin clinical trials. Over the past decade, publicly-financed organizations designed to bridge this “valley” with development grants have created a track record with notable success stories. Such non-dilutive funding sources reduce risks during the proof-of-concept stage and make investments more attractive to equity investors. Panelists in this session will explore the characteristics of academic spinouts that continued past the grant stage to attract major and repeated investments from venture capital as well as that demonstrated therapeutic progress.
Moderator: Simone Fishburn, PhD, Editor, BioCentury and BioCentury Innovations